Please try another search
The fundamental investment objective of this Fund is to provide long-term capital growth by investing primarily in a diversified portfolio of equity and equity-related securities of publicly traded companies registered, or with an official listing, on a stock exchange in the People’s Republic of China, as well as investing in securities of public companies that have a significant business or investment link with China. The Fund will invest primarily in equity securities issued by large, actively traded companies. The portfolio may also include securities in appropriate smaller companies and equity-related securities including, but not limited to, Chinese warrants and participation notes.
Name | Title | Since | Until |
---|---|---|---|
Caroline Yu Maurer | Equity Research Analyst | 2020 | Now |
Arwen Y Liu | - | 2019 | 2020 |
Joy Yuan | - | 2019 | 2020 |
Biography | Joy Yuan is an Investment Director in the China-HK equity team and has been working in the industry since 2005. Prior to joining HSBC in 2011, Joy worked as a portfolio manager and head of research at Winnington Capital and was a China healthcare analyst at Beijing Gao Hua Securities, the Goldman Sachs China brokerage platform. She holds a Bachelor of Science degree in Biochemistry from Nanjing University (China) and a Ph.D degree in Biochemistry from the University of Western Ontario (Canada). She is also a CFA charterholder. | ||
Suk Man Chan | Portfolio Manager | 2004 | 2019 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review